Department of Bioartificial Organs, Institute for Frontier Medical Science, Kyoto University, Kyoto, Japan.
Gastrointest Endosc. 2011 Apr;73(4):777-84. doi: 10.1016/j.gie.2010.11.008. Epub 2011 Jan 26.
EMR is an accepted treatment for early esophageal carcinoma. However, resection of a large mucosal area often causes postoperative esophageal stricture.
To investigate the efficacy of autologous adipose tissue-derived stromal cells (ADSCs) for prevention of stricture formation after EMR in dogs.
Animal study.
University research center.
Ten beagle dogs were randomized into a control group and an ADSCs-injected (ADSC) group. The ADSCs were isolated from autologous adipose tissue. Immediately after circumferential esophageal EMR, about 5 × 10(6) ADSCs suspended in 8 mL of phosphate-buffered saline solution were injected endoscopically into the residual submucosa of the ADSC group, whereas the control group received only 8 mL of phosphate-buffered saline solution.
Dysphagia score, weight loss, rate of mucosal constriction, and histologic assessments.
In the control and ADSC groups, the median dysphagia scores were 4 and 1 (P < .043), the mean degrees of mucosal constriction were 75.7% and 45.3% (P < .008), and the numbers of nascent microvessels in the submucosal layer were 7.4 and 16.2 per unit area (P = .007), respectively. Atrophy and fibrosis of the muscularis propria layer were observed in the control group.
Animal study, small sample size.
Injection therapy with autologous ADSCs suppresses constriction of the esophageal mucosa and improves clinical symptoms after circumferential EMR in this canine model.
EMR 是治疗早期食管癌的一种公认方法。然而,切除大面积的黏膜区域常常导致术后食管狭窄。
研究自体脂肪组织来源的基质细胞(ADSCs)预防犬 EMR 后狭窄形成的疗效。
动物研究。
大学研究中心。
10 只比格犬随机分为对照组和 ADSC 注射(ADSC)组。ADSCs 从自体脂肪组织中分离出来。在 EMR 后立即将约 5×106 个 ADSCs 混悬于 8ml 磷酸盐缓冲液中通过内镜注入 ADSC 组的残余黏膜下层,而对照组仅接受 8ml 磷酸盐缓冲液。
吞咽困难评分、体重减轻、黏膜收缩率和组织学评估。
在对照组和 ADSC 组中,中位吞咽困难评分分别为 4 分和 1 分(P<.043),黏膜收缩程度的平均值分别为 75.7%和 45.3%(P<.008),黏膜下层新生微血管的数量分别为 7.4 个和 16.2 个/单位面积(P=0.007)。对照组观察到固有肌层的萎缩和纤维化。
动物研究,样本量小。
在该犬模型中,自体 ADSC 注射疗法可抑制 EMR 后食管黏膜的收缩,并改善临床症状。